DE HB62 | 2021-2022 | 151st General Assembly

Status

Spectrum: Moderate Partisan Bill (Democrat 18-2)
Status: Introduced on January 7 2021 - 25% progression
Action: 2021-01-07 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]

Summary

This Act is based on a Model Act to Prevent Excessive and Unconscionable Prices for Prescription Drugs developed by the National Academy for State Health Policy. It prohibits manufacturers from raising the price of prescription drugs outside of certain market conditions that might justify a price hike. It is specifically limited to the prices charged to consumers in the State of Delaware for generic and off-patent drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act To Amend Title 6 Of The Delaware Code Relating To The Prohibition Of Excessive And Unconscionable Prices For Prescription Drugs.

Sponsors


History

DateChamberAction
2021-01-07 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Delaware State Sources


Bill Comments

feedback